Dalcetrapib - CISMeF

Preferred Label : Dalcetrapib;

NCIt definition : A cholesteryl ester transfer protein (CETP) inhibitor that can produce an increase in serum HDL-cholesterol levels and a decrease in serum LDL-cholesterol levels. Dalcetrapib is structurally dissimilar from other CETP inhibitors, including torcetrapib, and raises functional HDL by a different mechanism.;

UNII : 3D050LIQ3H;

InChIKey : YZQLWPMZQVHJED-UHFFFAOYSA-N;

CAS number : 211513-37-0;

Molecule name : R1658;

Chemical formula : C23H35NO2S;

Details

Origin ID

C81529;

UMLS CUI

C2713495;

Currated CISMeF NLP mapping
- dalcetrapib [MeSH concept]
- dalcetrapib [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- dalcetrapib [MeSH Supplementary Concept]
- dalcetrapib [MeSH concept]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
- NCIt COVID-19 Agent Terminology [NCIt concept]
- NCIt COVID-19 Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients